Another win for mimetic peptides in stroke: Disruption of TRPM2-NMDAR signaling
- 1 June 2022
- journal article
- editorial
- Published by Elsevier BV in Neuron
- Vol. 110 (12), 1881-1884
- https://doi.org/10.1016/j.neuron.2022.05.020
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injuryNeuron, 2022
- Excitotoxicity: Still Hammering the Ischemic Brain in 2020Frontiers in Neuroscience, 2020
- Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectantsScience, 2020
- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trialThe Lancet, 2020
- Targeting NMDA receptors in stroke: new hope in neuroprotectionMolecular Brain, 2018
- Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicityNature Neuroscience, 2016
- Modulation of NMDAR Subunit Expression by TRPM2 Channels Regulates Neuronal Vulnerability to Ischemic Cell DeathJournal of Neuroscience, 2013
- Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brainNature, 2012
- Sex Differences in Neuroprotection Provided by Inhibition of TRPM2 Channels following Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2011
- Protein kinase C modulates NMDA receptor trafficking and gatingNature Neuroscience, 2001